Atossa Therapeutics, Inc. (BMV:ATOS)

Mexico flag Mexico · Delayed Price · Currency is MXN
16.00
0.00 (0.00%)
At close: Jun 20, 2025, 2:00 PM CST
-16.23%
Market Cap 2.14B
Revenue (ttm) n/a
Net Income (ttm) -538.44M
Shares Out n/a
EPS (ttm) -4.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 126
Open 16.00
Previous Close 16.00
Day's Range 16.00 - 16.00
52-Week Range 13.00 - 31.00
Beta n/a
RSI 56.98
Earnings Date Aug 13, 2025

About Atossa Therapeutics

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company’s lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Thera... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 15
Stock Exchange Mexican Stock Exchange
Ticker Symbol ATOS
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.